• Capricor Therapeutics (CAPR) Downgraded by Zacks Investment Research

    Capricor Therapeutics (NASDAQ:CAPR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to …

    Read More
  • 0 0